Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Degos

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Nature|August 2, 1990
Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regionS J Lu, N E Day, L Degos, et al.
Leukemia|December 1, 1990
The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemiasC Chomienne, P Ballerini, N Balitrand, et al.
Oncogene|April 6, 1995
The PML growth-suppressor has an altered expression in human oncogenesisM H Koken, G Linares-Cruz, F Quignon, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETON Da Silva, S Meyer-Monard, M L Menot, et al.
Leukemia|August 30, 2002
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapyN Boissel, J M Cayuela, C Preudhomme, et al.
Experimental Cell Research|December 15, 1996
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenicC Andre, M C Guillemin, J Zhu, et al.
Blood|March 1, 1981
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cellsL Boumsell, A Bernard, E L Reinherz, et al.
Leukemia & Lymphoma|December 28, 1999
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatmentJ N Bastie, D Cazals-Hatem, M T Daniel, et al.
Leukemia|March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)C Kelaidi, L Ades, S Chevret, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Nature|August 2, 1990
Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA regionS J Lu, N E Day, L Degos, et al.
Leukemia|December 1, 1990
The retinoic acid receptor alpha gene is rearranged in retinoic acid-sensitive promyelocytic leukemiasC Chomienne, P Ballerini, N Balitrand, et al.
Oncogene|April 6, 1995
The PML growth-suppressor has an altered expression in human oncogenesisM H Koken, G Linares-Cruz, F Quignon, et al.
Leukemia|July 30, 2003
Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experienceI Lobe, F Rigal-Huguet, A Vekhoff, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Functional G-CSF pathways in t(8;21) leukemic cells allow for differentiation induction and degradation of AML1-ETON Da Silva, S Meyer-Monard, M L Menot, et al.
Leukemia|August 30, 2002
Prognostic significance of FLT3 internal tandem repeat in patients with de novo acute myeloid leukemia treated with reinforced courses of chemotherapyN Boissel, J M Cayuela, C Preudhomme, et al.
Experimental Cell Research|December 15, 1996
The PML and PML/RARalpha domains: from autoimmunity to molecular oncology and from retinoic acid to arsenicC Andre, M C Guillemin, J Zhu, et al.
Blood|March 1, 1981
Surface antigens on malignant Sézary and T-CLL cells correspond to those of mature T cellsL Boumsell, A Bernard, E L Reinherz, et al.
Leukemia & Lymphoma|December 28, 1999
Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatmentJ N Bastie, D Cazals-Hatem, M T Daniel, et al.
Leukemia|March 17, 2006
Late first relapses in APL treated with all-trans-retinoic acid- and anthracycline- based chemotherapy: the European APL group experience (APL 91 and APL 93 trials)C Kelaidi, L Ades, S Chevret, et al.
Pageof 34